Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH.
Alkhouri N, LaCerte C, Edwards J, Poordad F, Lawitz E, Lee L, Karan S, Sawhney S, Erickson M, MacConell L, Zaru L, Chen J, Campagna J.
Alkhouri N, et al. Among authors: campagna j.
Liver Int. 2024 Apr;44(4):966-978. doi: 10.1111/liv.15816. Epub 2024 Jan 31.
Liver Int. 2024.
PMID: 38293761
Clinical Trial.